Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Limited AAA Screening Recommended By U.S. Preventive Services Task Force

This article was originally published in The Gray Sheet

Executive Summary

Passage of the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) bill would expand screening to populations not covered under new U.S. Preventive Services Task Force recommendations

You may also be interested in...



SAAAVE

Screening Abdominal Aortic Aneurysms Very Efficiently bill (S 390) introduced Feb. 15 by Sens. Chris Dodd (D-Conn.) and Jim Bunning (R-KY). The bipartisan bill would expand screening to populations not covered by new U.S. Preventive Services Task Force recommendations (1"The Gray Sheet" Feb. 7, 2005, p. 16)...

SAAAVE

Screening Abdominal Aortic Aneurysms Very Efficiently bill (S 390) introduced Feb. 15 by Sens. Chris Dodd (D-Conn.) and Jim Bunning (R-KY). The bipartisan bill would expand screening to populations not covered by new U.S. Preventive Services Task Force recommendations (1"The Gray Sheet" Feb. 7, 2005, p. 16)...

AHRQ To Update AAA Screening Stance In November

The Agency for Healthcare Research & Quality's U.S. Preventive Services Task Force will vote on a proposed recommendation for abdominal aortic aneurysm (AAA) screening in November, AHRQ Director Carolyn Clancy, MD, reported Sept. 21 on Capitol Hill

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel